Document:

Document

Execution Version

SUPPORT AGREEMENT
THIS AGREEMENT is effective as of May 11, 2022.
BETWEEN:
EMERALD HEALTH SCIENCES INC., a corporation existing under the laws of the Province of British Columbia
(the “Securityholder”)
AND:
EMERALD HEALTH THERAPEUTICS, INC., a corporation existing under the laws of the Province of British Columbia,
(“EHT”).

WHEREAS:
A.Skye Bioscience, Inc. (the “Company” or “SKYE”) and EHT have entered into a definitive arrangement agreement (the “Definitive Agreement”) concurrent with the entering into of this Agreement providing for an arrangement of EHT pursuant to Section 288 of the Business Corporations Act (British Columbia) which will result, inter alia, in the acquisition by the Company of all of the issued and outstanding shares in the capital of EHT in consideration for the issuance of shares of the Company to shareholders of the EHT pursuant to the terms thereof (the “Transaction”);
B.The Securityholder or its affiliates (which includes for the purposes of this Agreement, any entity controlled by the Securityholder or an affiliate of any entity controlled by the Securityholder) beneficially own or have voting or dispositive power over the number of shares in the capital of the Company (the “Shares”) and other securities of SKYE (including SKYE Options, SKYE Warrants, SKYE RSUs, and other convertible debt), if any, set forth in Schedule A of this Agreement (the Shares and such other securities are collectively referred to herein as the “Securities”); and
C.The Securityholder acknowledges that EHT would not enter into the Definitive Agreement but for the execution and delivery of this Agreement by the Securityholder.
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the covenants and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.Definitions. All terms used in this Agreement that are not defined herein and that are defined in the Definitive Agreement shall have the respective meanings ascribed to them in the Definitive Agreement. The term “beneficially owns” or “beneficial owner” has the meaning assigned to such term in Rule 13d-3 under the Securities Exchange Act of 1934, as amended.

2.Representations of the Securityholder.  The Securityholder represents and warrants to EHT that (and acknowledges that EHT is relying upon such representations and warranties):

(a)it or one of its affiliates is the sole registered owner and / or beneficial owner of the Shares (the “Owned Shares”) and other Securities set forth in Schedule A of this Agreement (together with the Owned Shares, the “Owned Securities”) with good title thereto free of any and all encumbrances and demands of any nature or kind whatsoever;

(b)other than the Definitive Agreement, this Agreement and the clawback provisions of any relevant equity incentive plan of the Company, no person has any agreement or option, or 
328972.00001/116955760.3
			
	SF-4826580.3 

- 2 -

any right or privilege, whether by law, pre-emptive or contractual, capable of becoming an agreement or option, for the exchange, acquisition or transfer from the Securityholder or any of its affiliates of any of the Owned Securities or any interest therein or right thereto;

(c)it or one of its affiliates has sole voting power and exclusive right of disposition with respect to the Owned Securities and sole power to agree to all matters set forth in this Agreement and neither the Securityholder nor any of its affiliates has previously granted or agreed to grant a proxy or other right to vote in respect of such Securities or entered into any voting trust, pooling or other agreement with respect to the right to vote, call meetings of securityholders or give consents or approvals of any kind as to such Securities except those which are no longer of force or effect;

(d)neither it nor any of its affiliates beneficially owns or controls any securities of the Company other than the Owned Securities;

(e)it has the legal capacity to execute and deliver this Agreement and to consummate the transactions contemplated hereby.  This Agreement has been duly executed and delivered by the Securityholder and, assuming the due authorization, execution and delivery by EHT, this Agreement constitutes the legal, valid and binding obligation of the Securityholder, enforceable in accordance with its terms, subject to laws of general application and bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and general principles of equity; and

(f)except as may be set forth in the Definitive Agreement or as otherwise required by law (including, without limitation, filings as may be required under applicable securities laws), no filing with, and no permit, authorization, consent, or approval of, any Governmental Entity is necessary for the execution of this Agreement by the Securityholder and the performance by the Securityholder of its obligations under this Agreement, and none of the execution and delivery of this Agreement by the Securityholder, the performance by the Securityholder of its obligations under this Agreement or compliance by the Securityholder with any of the provisions of this Agreement shall (i) conflict with or result in any breach of the organizational documents, if applicable, of the Securityholder, (ii) result in a material violation or material breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions or provisions of any material note, bond, mortgage, indenture, license, contract, commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which the Securityholder is a party, or (iii) violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to the Securityholder, except in each case under clauses (ii) and (iii), where the absence of filing or authorization, conflict, violation, breach, or default would not materially impair or materially adversely affect the ability of the Securityholder to perform the Securityholder's obligations hereunder on a timely basis.

3.Representations of EHT.  EHT represents and warrants to the Securityholder that (and acknowledges that the Securityholder is relying upon such representations and warranties): 

(a)EHT is, and will be as at the effective time of the Transaction, a company validly existing under the laws of the Province of British Columbia; 

(b)it has the requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder;

(c)it has full power and authority to make, enter into and carry out the terms of this Agreement and the Definitive Agreement;
			
	SF-4826580.3 

Execution Version

(d)this Agreement has been duly executed and delivered by EHT and, assuming the due authorization, execution and delivery by the Securityholder, this Agreement constitutes the legal, valid and binding obligation of EHT, enforceable in accordance with its terms, subject to laws of general application and bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and general principles of equity; and

(e)there are no legal proceedings in progress or pending before any Governmental Entity, or to the knowledge of EHT, threatened against EHT or its affiliates that would adversely affect in any manner the ability of EHT to enter into this Agreement or the Definitive Agreement and to perform its obligations hereunder or thereunder.   

4.Agreement to Vote Securities.  The Securityholder hereby agrees that at any meeting of the securityholders of the Company (or any class thereof), however called, or at any adjournment or postponement thereof, or in connection with any written consent of the securityholders of the Company (or any class thereof) or in any other circumstances upon which a vote, consent or other approval of all or some of the securityholders of the Company is sought (collectively, a “Meeting”), the Securityholder shall (or cause its affiliates or other holder of record to, if the Securityholder is the beneficial owner but not the holder of record of any of the Securities):

(a)vote all the Owned Shares which it holds as of the record date for such Meeting in favour of the Transaction contemplated and any actions required in furtherance thereof or otherwise contemplated by the Definitive Agreement.  The Securityholder shall also cause such Shares to be counted as present for purposes of establishing a quorum at such Meeting; and

(b)vote all the Owned Shares which it holds as of the record date for such Meeting against the following actions (other than pursuant to the Transaction): (i) any Acquisition Proposal; and/or (ii) any other matter that would reasonably be regarded as being directed towards or likely to prevent, delay, impede or interfere with the consummation of the Transaction;
and, no later than 10 days prior to any Meeting, each Securityholder will deliver or cause to be delivered (including by instructing any intermediary through which the Securityholder holds the Owned Shares to arrange for such delivery) to the Company’s transfer agent, or as otherwise directed by EHT, a duly executed proxy (or other appropriate voting instrument) appointing as proxyholders those individuals designated by the Company in the proxy statement disseminated by the Company in connection with the Meeting, or such other individuals as EHT may direct, and directing that the Owned Shares be voted at the Meeting in favour of the Transaction and all related matters, and thereafter not take any action to withdraw, amend or invalidate any such proxy (or other appropriate voting instrument) deposited by the Securityholder pursuant to this Agreement except in accordance with the terms hereof. 

Notwithstanding the foregoing, EHT and SKYE acknowledge and agree that the Securityholder’s votes shall not be counted for purposes of satisfying the closing condition in the Definitive Agreement related to obtaining the majority approval of the disinterested SKYE Shareholders (as defined therein).

5.No Voting Trusts.  The Securityholder will not, and will not permit any of its affiliates to, grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all the Owned Shares or deposit any of the Owned Shares in a voting trust or subject any of such Securities to any arrangement or agreement with respect to the voting of such securities, other than agreements entered into with EHT. 

6.Definition of Acquisition Proposal.  For the purposes of this Agreement, “Acquisition Proposal” means, other than the transactions contemplated by the Definitive Agreement, the transactions comprising the EHT Realization Process and any transaction involving only EHT and/or one or more of its wholly-owned Subsidiaries, any written or oral offer, proposal, expression of interest 
328972.00001/116955760.3
			
	SF-4826580.3 

- 4 -

or inquiry to SKYE or its shareholders from any person or group of persons (other than EHT or any of its Subsidiaries) made after the date hereof relating to: 

(a)any direct or indirect acquisition or sale (or lease, exchange, license, transfer or other arrangement having the same economic effect as a sale), whether in a single transaction or a series of related transactions, of: (a) assets of SKYE (including, without limitation, shares of one or more of its Subsidiaries) and/or one or more of its Subsidiaries that, individually or in the aggregate, constitute 20% or more of the consolidated assets of SKYE and its Subsidiaries or that contribute 20% or more of the consolidated revenue or net income of SKYE and its Subsidiaries; or (b) 20% or more of any class of outstanding voting or equity securities (or rights thereto) (and including securities convertible into or exercisable or exchangeable for voting or equity securities) of SKYE;

(b)any direct or indirect take-over bid, issuer bid, tender offer, exchange offer, treasury issuance or other transaction that, if consummated, would result in a person or group of persons acquiring beneficial ownership of 20% or more of any class of voting or equity securities of SKYE (and including securities convertible into or exercisable or exchangeable for voting or equity securities);

(c)any plan of arrangement, merger, amalgamation, consolidation, share exchange, business combination, reorganization, recapitalization, joint venture, partnership, liquidation, dissolution or other similar transaction involving SKYE or any one or more of its Subsidiaries that, individually or in the aggregate, constitute 20% or more of the consolidated assets of SKYE and its Subsidiaries or that contribute 20% or more of the consolidated revenue of SKYE and its Subsidiaries; or

(d)any other similar transactions involving SKYE economically and functionally equivalent to the foregoing.

7.No Action to Reduce Likelihood of Success or Delay.  The Securityholder hereby agrees that it will not, and will not permit any of its affiliates to directly or indirectly, do or authorize or permit any of its Representatives to do, any of the following:

(a)solicit, initiate or knowingly encourage or otherwise facilitate any Acquisition Proposal or any inquiries, proposals or offers relating to any Acquisition Proposal or that could reasonably be expected to lead to an Acquisition Proposal;

(b)enter into, engage in, continue or otherwise participate in any discussions or negotiations with any person (other than EHT) regarding any Acquisition Proposal or that could reasonably be expected to constitute or lead to an Acquisition Proposal;

(c)accept, approve, endorse or recommend, execute or enter into, or publicly propose to accept, approve, execute or enter into, any letter of intent, agreement in principle, agreement, arrangement, offer or understanding in respect of an Acquisition Proposal;

(d)furnish any information to any person in connection with a proposed Acquisition Proposal or otherwise assist, facilitate or encourage the making of, or cooperate in any way regarding, any Acquisition Proposal;

(e)solicit proxies or become a participant in a solicitation in opposition to or competition with EHT in connection with the Transaction; or

(f)assist any person, entity or group in taking or planning any action that would compete with, restrain or otherwise serve to interfere with or inhibit EHT in connection with the Transaction.
			
	SF-4826580.3 

Execution Version

8.No Dissent. If applicable, the Securityholder hereby agrees that it will not, and it will not permit any of its affiliates to exercise any dissent rights in respect of the Transaction and the Securityholder hereby waives and shall cause its affiliates to waive any rights of appraisal or rights of dissent from the Transaction that the Securityholder or any of its affiliates may have.

9.Transfer and Encumbrance.  Except with the prior written consent of EHT, the Securityholder and/or any of its affiliates shall not:

(a)directly or indirectly sell, transfer, gift, assign or otherwise dispose of or exchange any or all of its Owned Securities or enter into any agreement, arrangement or understanding in connection therewith (whether by actual disposition, derivative transaction or effective economic disposition through cash settlement and including the deposit of any securities under a takeover bid or tender offer), provided that, the Securityholder may (i) exercise options, warrants or any other convertible security to acquire additional Shares; (ii) transfer Owned Securities to its shareholders pursuant to a stock dividend, return of capital or other similar transaction (and for greater certainty, any such Owned Securities so transferred will cease to be subject to this Agreement); and (iii) transfer Owned Securities to a corporation or other entity directly or indirectly owned or controlled by the Securityholder or under common control with or controlling the Securityholder provided that (A) such transfer to a corporation or other entity shall not relieve or release the Securityholder of or from its obligations under this Agreement, including, without limitation the obligation of the Securityholder to vote or cause to be voted all its Owned Securities in favour of the Transaction, (B) prompt written notice of such transfer is provided to EHT, (C) the transferee agrees to be bound by the terms hereof pursuant to documentation approved in writing by EHT in advance of such transfer and (D) the transferee continues to be a corporation or other entity directly or indirectly owned or controlled by the Securityholder or under common control with or controlling the Securityholder, at all times prior to the Effective Date and agrees that, if such transferee ceases to be so controlled, it will immediately transfer such Owned Securities back to the transferor; 

(b)grant or enter into with any person any agreement or option, right or privilege (whether by law, pre-emptive or contractual) capable of becoming an agreement or option, for the exchange, acquisition or transfer from the Securityholder of any Owned Securities or any right or interest thereto; or

(c)allow any of its Owned Securities to become subject to any lien, pledge, mortgage, charge, restriction or security interest of any nature or kind whatsoever .

10.Additional Securities.  The Securityholder agrees that (a) any and all securities of the Company (collectively, “Additional Securities”) which the Securityholder or any of its affiliates acquires beneficial ownership of, or direction or control over, after the execution of this Agreement (including pursuant to the exercise of options, warrants or other convertible securities) shall be subject to the terms of this Agreement to the same extent as if they constituted Securities held by the Securityholder as of the date of this Agreement and the terms “Shares”, “Securities”, “Owned Shares” and “Owned Securities” as used herein will include all such securities; and (b) it will promptly notify EHT of any Additional Securities acquired by it or any of its affiliates after the date of this Agreement.

11.Disclosure.  The Securityholder agrees to the details of this Agreement being set out in any press release, information circular, proxy statement, disclosure document or court documents produced by the Company or EHT in connection with the Transaction and to this Agreement being made publicly available, including by filing on the System for Electronic Document Analysis and Retrieval (SEDAR) and the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). Except as required by law or applicable stock exchange requirements or as otherwise permitted by this Agreement, the Securityholder agrees that it will not, and will ensure that its associates 
328972.00001/116955760.3
			
	SF-4826580.3 

- 6 -

and affiliates do not, make any public announcement or public statements with respect to the transactions contemplated by this Agreement and the Definitive Agreement without the prior written approval of EHT.

12.EHT Acknowledgements.  EHT agrees and acknowledges that the Securityholder is bound hereunder solely in his, her or its capacity as a securityholder of the Company and that the provisions of this Agreement shall not be deemed or interpreted to bind the Securityholder or any of its directors, officers or principal shareholder in his, her or its capacity as a director, officer or shareholder of the Company or any of its subsidiaries. For the avoidance of doubt, nothing in this Agreement shall limit or restrict any party from properly fulfilling his fiduciary duties as a director or officer of the Company.

13.Termination.  Unless otherwise provided for herein, this Agreement shall terminate on the earliest of:

(a)EHT providing written notice of termination to the Securityholders;

(b)the termination of the Definitive Agreement in accordance with its terms; 

(c)the effective time of the Transaction;

(d)EHT, without the prior written consent of the Securityholder, decreasing the Share Consideration, and

(e)EHT, without the prior written consent of the Securityholder, changing the form of consideration set out in the Plan of Arrangement (other than to add additional consideration).

14.Effect of Termination.  If this Agreement is terminated in accordance with its terms, the provisions of this Agreement will become void and no party shall have liability to any other party, except in respect of a breach of this Agreement which occurred prior to such termination and the Securityholder shall be entitled to withdraw any form of proxy or power of attorney which it may have given with respect of the Shares. 

15.Specific Performance.  The Securityholder acknowledges that it will be impossible to measure in money the damage to EHT if the Securityholder fails to comply with any of its obligations under this Agreement, that every such obligation is material and that, in the event of any such failure, EHT will not have an adequate remedy at law or in damages and, accordingly, the Securityholder agrees that the issuance of an injunction or other equitable remedy is an appropriate remedy for any such failure. 

16.No Ownership Interest.  Nothing contained in this Agreement shall be deemed to vest in EHT any direct or indirect ownership or incidence of ownership at law or in equity with respect to any of the Securities or any right or entitlement to acquire or become the owner at law or in equity of the Securities. Any rights, ownership and economic benefits of and relating to the Securities shall remain vested in and belong to the Securityholder and its affiliates, as the case may be. EHT shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct the Securityholder or his affiliates in the voting of any of the Securities, except as otherwise provided herein, or in the performance of the Securityholder’s and its affiliates’ duties or responsibilities as a securityholder of the Company.  

17.Successors and Assigns.  The provisions of this Agreement shall be binding upon and enure to the benefit of the parties hereto and their respective successors and permitted assigns, provided that no party may assign, delegate or otherwise transfer any of its or his rights, interests or obligations under this Agreement without the prior written consent of the other party. 
			
	SF-4826580.3 

Execution Version

18.Entire Agreement.  This Agreement supersedes all prior agreements among the parties hereto with respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof.  

19.Amendments. This Agreement may not be modified or waived, except expressly by an instrument in writing signed by all the parties hereto.  

20.No Waiver.  No waiver of any provision hereof by any party shall be deemed a waiver by any other party nor shall any such waiver be deemed a continuing waiver of any matter by such party.

21.Notice.  Any demand, notice or other communication to be given in connection with this Agreement must be given in writing and will be given by electronic means of communication addressed to the recipient as follows: 
if to the Securityholder:    Email: []
if to EHT:                Emerald Health Therapeutics, Inc. 
    4226 Commerce Circle, Unit 101
    Victoria, BC V8Z 6N6
Attn: Mohammed Jiwan, Chief Operating Officer
Email: []
with a copy to:

Fasken Martineau DuMoulin S.E.N.C.R.L., s.r.l.:
    
800 Victoria Square, Suite 3500 
P.O. Box 242
Montréal, Quebec  
Canada, H4Z 1E9
    Attention: Neil Kravitz
    Fax Number:  (514) 397.7600
                        Email:[]
    and to: 

    Bennett Jones LLP:
                    2500 Park Place
666 Burrard Street
Vancouver, B.C.
Canada, V6C 2X8
Attention: James D. Beeby
    Fax Number:  (604) 891.5100
                        Email: []

Any demand, notice or other communication given by electronic communication, on the day of transmittal thereof if given during the normal business hours of the recipient and on the business day during which such normal business hours next occur if not given during such hours on any day.

22.Further Assurances.  Each of the parties hereto agrees to execute such further and other deeds, documents and assurances and to do such further and other acts as may be necessary to carry out the true intent and meaning of this Agreement fully and effectually.

23.Severability.  Each of the covenants, provisions, sections, subsections and other subdivisions hereof is severable from every other covenant, provision, section, subsection and subdivision and the invalidity or unenforceability of any one or more covenants, provisions, sections, subsections 
328972.00001/116955760.3
			
	SF-4826580.3 

- 8 -

and other subdivisions hereof shall not effect the validity or enforceability of the remaining covenants, provisions, sections, subsections or subdivisions hereof.

24.Miscellaneous.

(a)This Agreement shall be construed in accordance with the State of Nevada and the federal laws of the United States applicable therein without giving effect to any choice or conflict of law provision or rule that would cause the application of  laws of any jurisdiction other than the State of Nevada and the parties hereto agree to attorn to the jurisdiction of the courts thereof.

(b)This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

(c)All Section headings herein are for convenience of reference only and are not part of this Agreement and no construction or inference shall be derived therefrom.

[Remainder of the page intentionally left blank. Signature page follows.]

			
	SF-4826580.3 

Execution Version

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first above written.
EMERALD HEALTH THERAPEUTICS, INC.

per:
/s/ Mohammed Jiwan                
Authorized Signatory

EMERALD HEALTH SCIENCES INC.

per:
/s/ Jim Heppell                    
Authorized Signatory

[Signature Page to SKYE Support Agreement]
			
	SF-4826580.3 

SCHEDULE A
OWNERSHIP OF SECURITIES

															
	
Number of Shares	
Number of SKYE Options	Number of SKYE RSUs	
Number of SKYE Warrants	
Convertible Debt
	111,387,251	None.	None.	7,500,000	5,521,968

 
			
	SF-4826580.3Exhibit 10.02a Restricted Stock

		
			Exhibit 10.02a
		

		
			﻿
		

		
			RESTRICTED STOCK UNIT AWARD AGREEMENT
		

		
			﻿
		

		
			This Restricted Stock Unit Award Agreement (the “Agreement”) is made by and between Monro, Inc., a New York corporation with its principal executive offices at 200 Holleder Parkway, Rochester, New York 14615 (the “Company”) and _____________________ (the “Grantee”).
		

		
			The parties hereby agree as follows:
		

			
	
			
				 1.
			Grant of Restricted Stock Units.  Pursuant to the terms of the Company’s 2007 Stock Incentive Plan, as amended and restated (the “Plan”), the Company hereby grants to the Grantee, as of ______________________ (the “Date of Grant”), an award of Restricted Stock Units covering ___________ shares of the Company’s common stock, par value $.01 per share (the “Common Stock”), subject to the further conditions contained herein (the “RSUs”).

			
	
			
				 1.
			Vesting and Payment.

			
	
			
				 (a)
			Subject to the Grantee’s continued employment with the Company, the RSUs shall vest in accordance with the following schedule:

		
			﻿
		

		
			Time from Date of GrantPercent Vested
		

		
			One Year25%
		

		
			Two Years50%
		

		
			Three Years75%
		

		
			Four Years100%
		

			
	
			
				 (b)
			Subject to the Plan, except as expressly determined by the Compensation Committee of the Company’s Board of Directors (the “Committee”) in its sole discretion, the unvested portion of the Grantee’s RSUs shall terminate upon the Grantee’s termination of employment with the Company for any reason.  Notwithstanding the foregoing, in the event of the death of the Grantee, the unvested portion of the RSUs shall become fully vested.

			
	
			
				 (c)
			Vested RSUs shall be paid in shares of Common Stock promptly following the applicable vesting, but not later than sixty (60) days thereafter.

			
	
			
				 2.
			Dividend Equivalents.  Prior to the payment or forfeiture of the Grantee’s RSUs, there shall be accrued on the RSUs an amount equivalent to the regular cash dividends paid, if any, on the shares of Common Stock covered by the RSUs.  In the event of the vesting and payment of the RSUs, the dividend equivalents accrued on such vested RSUs, less any amounts that the Company determines are required to be withheld therefrom under Section 4, shall be paid at the time that the related vested RSUs are paid to the Grantee.  In the event of the forfeiture or cancellation of all or a portion of the RSUs, the dividend equivalents accrued on the portion of the RSUs that is forfeited shall also be forfeited.

		 

 

			
	
			
				 3.
			Tax Withholding.  The Company shall have the right to require that an amount sufficient to satisfy federal, state and local withholding tax requirements be remitted to the Company, or the Company may deduct from payments of the RSUs (or any dividend equivalents) amounts sufficient to satisfy all withholding tax requirements.  The Committee may, in its sole discretion, permit a Grantee to satisfy his or her minimum statutory tax withholding obligation, subject to the terms and conditions established by the Committee, by:  (i) surrendering shares of Common Stock owned by the Grantee having a fair market value equal to the amount of such taxes; (ii) directing the Company to withhold shares of Common Stock otherwise issuable to the Grantee in payment of the RSUs having a fair market value equal to the amount of such taxes; (iii) through the delivery of irrevocable instructions to a broker to deliver promptly to the Company an amount equal to the amount of such taxes; (iv) such other method approved by the Committee; or (v) any combination of the foregoing methods.

			
	
			
				 4.
			No Stockholder Rights.  Until the shares of Common Stock from the payment of the RSUs have been issued to the Grantee, the Grantee shall have no rights of a stockholder of the Company with respect to the shares of Common Stock covered by the RSUs, and in particular shall not be entitled to vote the covered shares of Common Stock or to receive any dividends paid or made with respect to the shares of Common Stock covered by the RSUs (other than any dividend equivalents under Section 3).

			
	
			
				 5.
			Transferability.  The RSUs may not be transferred, assigned, pledged or hypothecated (whether by operation of law or otherwise) other than by will or the applicable laws of descent and distribution, and shall not be subject to execution, attachment or similar process.

			
	
			
				 6.
			Binding Effect.  This Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and any executor, administrator, legal representative, legatee or distributee entitled by law to exercise the Grantee’s rights hereunder.

			
	
			
				 7.
			Stock Incentive Plan.  The Grantee hereby agrees to all the terms and provisions of the Plan and any future amendments thereto, which are expressly incorporated into the Agreement and made a part hereof as if printed herein; provided, that no modification or amendment of the Plan may, without the consent of the Grantee, adversely affect the rights of the Grantee under the Agreement.  A current copy of the Plan will be provided to the Grantee by the Company at any time and without charge, upon request.  Capitalized terms not otherwise defined in this Agreement shall have the same meaning as in the Plan.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.

			
	
			
				 8.
			Choice of Law.  This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflicts of laws principles thereof.

			
	
			
				 9.
			Clawback.  Notwithstanding anything in the Plan or in this Agreement to the contrary, in order to comply with Section 10D of the Securities Exchange Act of 1934, as amended, and any regulations promulgated, or national securities exchange listing conditions adopted, with respect thereto (collectively, the “Clawback Requirements”), the Company will be entitled to recoup compensation of whatever kind paid under the Plan and this Agreement at any time, in accordance with the Clawback Requirements and any policy adopted by the Company pursuant to 
		

		 

 

			the Clawback Requirements.  This could require the Grantee to return to the Company, or forfeit if not yet paid, the RSUs and the proceeds from the payment of the RSUs (including any dividend equivalents), in order to comply with the Clawback Requirements and any policy adopted by the Company pursuant to the Clawback Requirements.

			
	
			
				 10.
			Amendment.  The terms of the Agreement may be amended from time to time by the Committee, in its sole discretion, in any manner that the Committee deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Grantee under the Agreement without the written consent of the Grantee.

			
	
			
				 11.
			Adjustment Upon Changes in Capitalization.  In the event of any change in the outstanding shares of Common Stock after the Date of Grant by reason of any share dividend or split, reorganization, recapitalization, merger, consolidation, spin-off, combination or transaction or exchange of shares or other corporate exchange, or any distribution to shareholders of shares other than regular cash dividends or any transaction similar to the foregoing, to prevent dilution or enlargement of the Grantee’s rights under the Agreement, the Committee without liability to any person shall make such substitution or adjustment, as to (i) the number or kind of shares or other securities issued or reserved for issuance pursuant to the Agreement and/or (ii) any other affected terms of the Agreement, as the Committee, in its sole discretion, deems equitable or appropriate.

			
	
			
				 12.
			Signature in Counterparts.  This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

			
	
			
				 13.
			No Right to Continued Employment.  Nothing in the Plan or in this Agreement, nor the grant of the RSUs, shall confer upon the Grantee any right to continue in the employment of the Company or to be entitled to any remuneration or benefits not set forth in the Plan or this Agreement or interfere with or limit the right of the Company to modify the terms of or terminate such Grantee’s employment at any time.

			
	
			
				 14.
			Notices.  Notices required or permitted to be made under the Plan or this Agreement shall be sufficiently made if personally delivered to the Grantee or sent by regular mail addressed:  (i) to the Grantee at the Grantee’s address as set forth in the books and records of the Company; or (ii) to the Company or the Committee at the principal office of the Company clearly marked “Attention:  Compensation Committee.”

			
	
			
				 15.
			Section 409A.  The RSUs and any dividend equivalents granted under this Agreement are intended to be exempt from the requirements of Section 409A of the Code, and the official guidance issued thereunder (collectively, “Section 409A”) under the short-term deferral exception thereto, and the Plan and this Agreement will be interpreted in a manner consistent with that intent.  Notwithstanding the foregoing, the Company and its subsidiaries make no representations that the RSUs or any dividend equivalents, or the grant, vesting or payment thereof provided under this Agreement comply with or are exempt from Section 409A, and in no event shall the Company or its subsidiaries be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by a Grantee on account of non-compliance with Section 409A.

		

		

		 

 

		IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer, and the Grantee has hereunto set his hand, as of the _____ day of ___________________.
		

		
			﻿
		

		
			GRANTEE:MONRO, INC.
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			__________________________________By:______________________________________
		

		
			Michael T. Broderick, President and Chief Executive Officer
		

		
			﻿

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]